Haanen JBAG - Search Results

1

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.

de Gooyer PGM, Verschoor YL, van den Dungen LDW, Balduzzi S, Marsman HA, Geukes Foppen MH, Grootscholten C, Dokter S, den Hartog AG, Verbeek WHM, Woensdregt K, van den Broek JJ, Oosterling SJ, Schumacher TN, Kuhlmann KFD, Beets-Tan RGH, Haanen JBAG, van Leerdam ME, van den Berg JG, Chalabi M. de Gooyer PGM, et al. Among authors: haanen jbag. Nat Med. 2024 Nov;30(11):3284-3290. doi: 10.1038/s41591-024-03250-w. Epub 2024 Sep 15. Nat Med. 2024. PMID: 39278994 Free PMC article. Clinical Trial.

2

Systemic T cell expansion during localized viral infection.

Haanen JB, Toebes M, Cordaro TA, Wolkers MC, Kruisbeek AM, Schumacher TN. Haanen JB, et al. Eur J Immunol. 1999 Apr;29(4):1168-74. doi: 10.1002/(SICI)1521-4141(199904)29:04<1168::AID-IMMU1168>3.0.CO;2-J. Eur J Immunol. 1999. PMID: 10229083 Free article.

3

Selective expansion of cross-reactive CD8(+) memory T cells by viral variants.

Haanen JB, Wolkers MC, Kruisbeek AM, Schumacher TN. Haanen JB, et al. J Exp Med. 1999 Nov 1;190(9):1319-28. doi: 10.1084/jem.190.9.1319. J Exp Med. 1999. PMID: 10544203 Free PMC article.

4

Tracing and characterization of the low-avidity self-specific T cell repertoire.

de Visser KE, Cordaro TA, Kioussis D, Haanen JB, Schumacher TN, Kruisbeek AM. de Visser KE, et al. Eur J Immunol. 2000 May;30(5):1458-68. doi: 10.1002/(SICI)1521-4141(200005)30:5<1458::AID-IMMU1458>3.0.CO;2-2. Eur J Immunol. 2000. PMID: 10820394 Free article.

5

In situ detection of virus- and tumor-specific T-cell immunity.

Haanen JB, van Oijen MG, Tirion F, Oomen LC, Kruisbeek AM, Vyth-Dreese FA, Schumacher TN. Haanen JB, et al. Nat Med. 2000 Sep;6(9):1056-60. doi: 10.1038/79573. Nat Med. 2000. PMID: 10973329 No abstract available.

6

In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens.

Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, Schumacher TN, Haanen JB, Mutis T, Goulmy E. Dickinson AM, et al. Nat Med. 2002 Apr;8(4):410-4. doi: 10.1038/nm0402-410. Nat Med. 2002. PMID: 11927949

7

Optimizing the efficacy of epitope-directed DNA vaccination.

Wolkers MC, Toebes M, Okabe M, Haanen JB, Schumacher TN. Wolkers MC, et al. J Immunol. 2002 May 15;168(10):4998-5004. doi: 10.4049/jimmunol.168.10.4998. J Immunol. 2002. PMID: 11994451

8

On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients.

van Oijen M, Bins A, Elias S, Sein J, Weder P, de Gast G, Mallo H, Gallee M, Van Tinteren H, Schumacher T, Haanen J. van Oijen M, et al. Clin Cancer Res. 2004 Jul 15;10(14):4754-60. doi: 10.1158/1078-0432.CCR-04-0260. Clin Cancer Res. 2004. PMID: 15269149

9

A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression.

Bins AD, Jorritsma A, Wolkers MC, Hung CF, Wu TC, Schumacher TN, Haanen JB. Bins AD, et al. Nat Med. 2005 Aug;11(8):899-904. doi: 10.1038/nm1264. Epub 2005 Jun 19. Nat Med. 2005. PMID: 15965482 Free article.

10

Design and use of conditional MHC class I ligands.

Toebes M, Coccoris M, Bins A, Rodenko B, Gomez R, Nieuwkoop NJ, van de Kasteele W, Rimmelzwaan GF, Haanen JB, Ovaa H, Schumacher TN. Toebes M, et al. Nat Med. 2006 Feb;12(2):246-51. doi: 10.1038/nm1360. Epub 2006 Feb 5. Nat Med. 2006. PMID: 16462803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters